Clobazam%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528oral%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520formulation%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

## Clobazam (Oral Formulation) ### Overview Clobazam is a benzodiazepine with anticonvulsant properties, primarily used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS). ### Primary Indications * Adjunctive treatment of seizures in patients with Lennox-Gastaut syndrome (LGS). ### Adult Dosing * **Initial:** 5 mg twice daily. * **Maintenance:** Dose can be titrated upward based on clinical response and tolerability, not more often than weekly. * **Maximum:** 20 mg twice daily (40 mg/day). * **Note:** Dosing for other indications may vary and should be guided by specific clinical protocols or guidelines. ### Pediatric Dosing (LGS) * **Initial (2-10 years):** 5 mg twice daily. * **Initial (≥10 years or weight >30 kg):** 10 mg twice daily. * **Maintenance:** Dose can be titrated upward based on clinical response and tolerability, not more often than weekly. * **Maximum (2-10 years):** 10 mg twice daily (20 mg/day). * **Maximum (≥10 years or weight >30 kg):** 20 mg twice daily (40 mg/day). * **Weight-based adjustments:** For children weighing 30 kg or less, consider lower doses. ### Dose Adjustments * **Hepatic Impairment:** Use with caution. No specific dose adjustments are established, but lower starting doses and slower titration may be warranted. * **Renal Impairment:** Use with caution. No specific dose adjustments are established, but lower starting doses and slower titration may be warranted. ### Contraindications * Known hypersensitivity to clobazam or other benzodiazepines. ### Adverse Effects * **Common:** Somnolence, decreased appetite, constipation, aggression, irritability, vomiting, fatigue, ataxia, gait disturbance. * **Serious:** Suicidal behavior or ideation, severe somnolence, withdrawal symptoms upon abrupt discontinuation, respiratory depression (especially when used with other CNS depressants). ### Key Drug Interactions * **CNS Depressants (e.g., opioids, alcohol, other benzodiazepines, sedating antihistamines):** Increased risk of profound sedation, respiratory depression, coma, and death. * **CYP2C19 Inhibitors (e.g., fluconazole, omeprazole):** May increase clobazam plasma concentrations. * **CYP2C19 Inducers (e.g., rifampin):** May decrease clobazam plasma concentrations. * **Phenobarbital, Phenytoin, Primidone:** Clobazam can increase levels of these anticonvulsants. ### Monitoring * Monitor for signs of sedation, respiratory depression, and behavioral changes. * Assess for efficacy in seizure control. * Monitor for signs of withdrawal if discontinuing the medication. * Consider monitoring plasma concentrations if efficacy is suboptimal or toxicity is suspected, especially with interacting medications. ### Clinical Pearls * Clobazam has a longer half-life than many other benzodiazepines, which can be beneficial for stable dosing but may also lead to accumulation. * Abrupt discontinuation can lead to withdrawal symptoms; taper gradually. * Patients with LGS may have increased sensitivity to benzodiazepine side effects. *** **Disclaimer:** This information is intended for clinical use and does not replace professional judgment. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.